Skip to main content

Find Clinical Trials

Home
Conditions
NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients

Clinical trial condition

NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients

Explore clinical trials studying NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients trial results

Active, Not Recruiting

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

NCT02869217

Conditions: Adnexal Diseases, Bladder Cancer, Digestive System Diseases, +52 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details